En esta página
01PALI precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
PALI Palisade Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$1,44
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,32mínimo 52 semanas
$2,86máximo 52 semanas
Capitalización Bursátil (MRQ)
$250M
P/E (TTM)
2.2
BPA (TTM)
$0.65
Ingresos (TTM)
$500.0K
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$10
P/E
2.2
ROE
-51.4%
Margen de Beneficio Neto
-6388.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
PALI Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.44
Capitalización Bursátil (MRQ)
$250M
P/E (TTM)
2.2
BPA (TTM)
$0.65
Ingresos (TTM)
$500.0K
ROE (TTM)
-51.4%
Rango 52S
$1–$3
PALI Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 8 de abril de 2024 | 1-for-15 | Inversa |
| 16 de noviembre de 2022 | 1-for-50 | Inversa |
| 28 de abril de 2021 | 1-for-6 | Inversa |
| 18 de julio de 2019 | 1-for-20 | Inversa |
| 9 de enero de 2017 | 1-for-13 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02016-12-31 → 2025-12-31
BPA$-0.302020-12-31 → 2025-12-31
Flujo de caja libre·2016-12-31 → 2024-12-31
Margen neto-6388.2%2016-12-31 → 2023-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | PALI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 2.2promedio 5A ≈-3.8 | ≈-3.8 | · | · | |
| P/S (TTM) | 500.0 | · | 12.0 | Sobrevalorado | |
| P/C (MRQ) | 2.1promedio 5A ≈382.8 | ≈382.8 | 6.9 | Infravalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | -21.2promedio 5A ≈-199.8 | ≈-199.8 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.8promedio 5A ≈382.8 | ≈382.8 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | PALI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -7069.8% | · | -303.8% | Débil | |
| Margen de Beneficio Neto (TTM) | -6388.2% | · | -391.6% | Débil | |
| ROA (TTM) | -47.7%promedio 5A ≈-133.0% | ≈-133.0% | -43.7% | De primer nivel | |
| ROE (TTM) | -51.4%promedio 5A ≈-182.7% | ≈-182.7% | -48.6% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | PALI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 24.3promedio 5A ≈9.4 | ≈9.4 | 4.0 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 28.8promedio 5A ≈9.0 | ≈9.0 | 3.9 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | PALI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 164.4% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | PALI | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.2 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
2.3%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.05 | $-0.05 | 6.2% |
| 31 de marzo de 2026 | May 11, 2026 | $-0.05 | $-0.04 | -14.4% |
| 31 de diciembre de 2025 | $-0.08 | $-0.08 | 3.5% | |
| 30 de septiembre de 2025 | $-0.38 | $-0.28 | -35.8% | |
| 30 de junio de 2025 | $-0.58 | $-0.57 | -1.4% | |
| 31 de marzo de 2025 | $-0.47 | $-0.71 | 34.2% | |
| 31 de diciembre de 2024 | $-1.55 | $-2.03 | 23.7% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $250.0K | $0 | · | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| R&D Expense | · | $16M | · | · | · | $2M | $4M | $4M | $8M | $13M | $13M | $8M | |
| SG&A Expense | $8M | $6M | $6M | $9M | $9M | $6M | $5M | $5M | $5M | $7M | $7M | $9M | |
| Operating Expenses | $18M | $15M | $13M | $16M | $42M | $9M | $9M | $9M | $14M | $21M | $19M | $17M | |
| Operating Income | $-18M | $-15M | $-13M | $-16M | $-42M | $-9M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M | |
| Interest Expense | · | $12.0K | $15.0K | $13.0K | $2M | $235.0K | $8.9K | $7.7K | $159.1K | $1M | $2M | $2M | |
| Interest Income | · | · | · | · | · | $33.5K | $67.7K | $78.8K | $70.3K | $58.8K | $69.5K | $67.7K | |
| Other Non-op | $1M | $433.0K | $785.0K | $3M | $47.0K | $13.0K | $280.0K | $3M | $-2M | $-437.8K | $-2M | $0 | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $1.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| EPS (Basic) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-142.95 | $-3.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | · | · | · | · | · | · | |
| Shares (Basic) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,195 | 2,774,370 | · | · | · | · | · | · | |
| Shares (Diluted) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,958 | 2,774,370 | · | · | · | · | · | · | |
| EBITDA | $-18M | $-15M | $-13M | $-16M | $-42M | $-11M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $10M | $12M | $12M | $10M | $713.0K | $5M | $6M | $7M | $15M | $5M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $5M | $5M | $8M | $15M | |
| Receivables | $0 | $0 | · | $0 | $0 | $59.0K | $21.1K | $294.1K | $312.8K | $10.5K | $37.3K | $225.5K | |
| Prepaid Expense | $836.0K | $673.0K | $896.0K | $2M | $1M | $124.0K | $510.9K | $363.3K | $402.3K | $646.2K | $1M | $274.1K | |
| Current Assets | $134M | $10M | $13M | $15M | $12M | $896.0K | $6M | $7M | $12M | $21M | $13M | $28M | |
| PP&E (Net) | $0 | $3.0K | $10.0K | $10.0K | $3.0K | $5.0K | $41.0K | $90.3K | $172.9K | $269.6K | $343.2K | $301.3K | |
| PP&E (Gross) | · | · | · | · | · | $916.0K | $991.5K | $992.6K | $994.8K | $994.3K | $971.8K | $784.5K | |
| Accum. Depreciation | · | · | · | · | · | $905.2K | $950.4K | $902.3K | $821.9K | $724.8K | $628.6K | $483.2K | |
| Intangibles | · | · | · | · | · | $147.1K | $668.9K | $763.5K | $883.5K | $990.2K | $1M | $1M | |
| Other Non-current Assets | $68.0K | $273.0K | $490.0K | $694.0K | $868.0K | · | · | $24.0K | $13.9K | $15.7K | $71.8K | $58.7K | |
| Total Assets | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Accounts Payable | $767.0K | $1M | $698.0K | $2M | $1M | $3M | · | · | · | · | · | · | |
| Accrued Liabilities | $2M | $1M | $831.0K | $574.0K | $463.0K | $3M | · | · | · | · | · | · | |
| Current Liabilities | $5M | $3M | $3M | $3M | $2M | $8M | $1M | $1M | $2M | $7M | $6M | $4M | |
| Capital Leases | · | $0 | $90.0K | $211.0K | $0 | $112.0K | $148.5K | · | · | · | · | · | |
| Other Non-current Liabilities | · | $150.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $3M | $3M | $3M | $5M | $10M | $1M | $2M | $5M | $11M | $10M | $12M | |
| Long-term Debt | · | · | · | · | $87.0K | $1M | · | · | · | · | $8M | $9M | |
| Total Debt | · | · | · | · | $87.0K | · | · | · | · | $4M | $8M | $9M | |
| Common Stock | $2M | $27.0K | $6.0K | $30.0K | $3.0K | $28.0K | $38.7K | $9.1K | $151.6K | $110.3K | $70.8K | $877.9K | |
| Paid-in Capital | $281M | $143M | $133M | $122M | $102M | $51M | $227M | $220M | $217M | $204M | $177M | $168M | |
| Retained Earnings | · | $136M | $122M | $109M | $95M | $-68M | $-222M | $-214M | $-209M | $-193M | $-172M | $-151M | |
| AOCI | · | · | · | · | · | $-734 | $-6.2K | $-413 | $2.6K | $3.9K | $3.1K | $6.0K | |
| Stockholders' Equity | $129M | $7M | $11M | $12M | $7M | $-17M | $-8M | $6M | $9M | $11M | $5M | $18M | |
| Liabilities + Equity | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Shares Outstanding | 159,444,017 | 2,768,646 | 618,056 | 2,944,306 | 284,780 | 2,774,502 | 3,866,457 | 910,253 | 15,160,014 | 11,032,858 | 7,077,362 | 87,789,679 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3.0K | $2.0K | $3.0K | $143.9K | $185.8K | $289.2K | $337.5K | $345.5K | $348.6K | |
| Stock-based Comp | $4M | $652.0K | $624.0K | $1M | $2M | $2M | $880.8K | $634.1K | $2M | $3M | $3M | $4M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $456.0K | $-3M | $19M | $-7M | $-8M | $-6M | |
| Amort. of Intangibles | · | · | · | · | · | $63.0K | $95.0K | $102.0K | $189.0K | $176.0K | $197.0K | $211.0K | |
| Operating Cash Flow | $-11M | $-12M | $-11M | $-13M | $-15M | $-5M | $-7M | $-8M | $-13M | $-16M | $-19M | $-12M | |
| CapEx | · | $0 | $4.0K | $10.0K | $0 | $6.0K | · | $1.7K | $11.4K | $98.1K | $176.3K | $207.9K | |
| Investing Cash Flow | · | $0 | $-4.0K | $-10.0K | $-54.0K | $-6.0K | · | $5M | $-94.0K | $2M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $4M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $-4M | $-5M | $-1M | $2M | |
| Stock Issued | $128M | $8M | $9M | $14M | $5M | $1M | · | · | · | · | $3M | · | |
| Net Stock Activity | $128M | $8M | $9M | $14M | $5M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $134M | $10M | $11M | $15M | $25M | $2M | $7M | $2M | $5M | $24M | · | · | |
| Net Change in Cash | $124M | $-3M | $49.0K | $2M | $10M | $-3M | $-672.2K | $-887.8K | $-9M | $10M | $-8M | $-4M | |
| Free Cash Flow | · | $-12M | $-11M | $-13M | $-15M | · | · | $-8M | $-13M | $-16M | $-19M | $-12M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| Net Margin | · | · | -4920.0% | · | · | -120316.7% | -54252.6% | -1894.1% | -6025.4% | -129721.8% | -200671.0% | -120154.7% | |
| EBITDA Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| ROA | -23.1% | -115.8% | -82.5% | -100.9% | -342.8% | -165.7% | -117.1% | -45.7% | -85.9% | -112.2% | -93.1% | -91.9% | |
| ROE | -25.4% | -204.8% | -96.9% | -114.5% | -471.7% | 1056.6% | -137.3% | -93.5% | -157.9% | -258.6% | -184.3% | -173.2% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 | 4.0 | 4.6 | 6.2 | 8.2 | 2.9 | 2.1 | 7.0 | |
| Quick Ratio | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 | 3.3 | 4.2 | 5.8 | 7.9 | 2.8 | 1.9 | 6.9 | |
| Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | 0.3 | 1.6 | 0.5 | |
| LT Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | · | 0.7 | 0.5 | |
| Interest Coverage | · | -1238.2 | -871.3 | -1209.3 | -17.5 | -761.7 | -967.7 | -1072.9 | -83.7 | -18.1 | -10.5 | -10.8 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 0.2 | 0.1 | 0.9 | 1.6 | 0.7 | 0.1 | 0.2 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.81 | $2.71 | $1.22 | $4.24 | $0.52 | $0.56 | $1.33 | $0.33 | $0.56 | $1.03 | $0.05 | $0.20 | |
| Revenue / Share | $0.00 | $0.00 | $0.04 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.19 | $-8.61 | $-1.63 | $-15.18 | $-1.58 | · | · | · | · | · | · | · | |
| Cash / Share | $0.84 | $3.55 | $1.34 | $4.21 | $0.74 | $0.61 | $1.32 | $0.32 | $0.44 | $1.38 | $0.05 | $0.14 | |
| EPS (TTM) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | · | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue CAGR 3Y | · | · | 164.4% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $250.0K | $0 | $13.5K | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| Net Income TTM | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| Market Cap | $375M | $5M | $82M | $230M | $13.88B | $68.49B | $17.23B | $507.92B | $2.35T | $3.49T | $110.88T | $279.38T | |
| Enterprise Value | · | · | · | · | $13.87B | · | · | · | · | $3.49T | $110.88T | $279.38T | |
| P/E | -7.8 | -0.2 | -0.3 | -4.7 | -5.7 | -1064.5 | · | · | · | · | · | · | |
| P/S | · | · | 328.2 | · | 1026863.7 | 5065901.2 | 1118946.7 | 1953543.0 | 9026039.1 | 214531567.3 | 10643762608.8 | 14834698372.5 | |
| P/B | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | 7011.8 | 3360.3 | 83960.2 | 275600.1 | 307594.0 | 22321294.5 | 15767062.3 | |
| P / Tangible Book | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -34.5 | -0.4 | -7.4 | -17.2 | -939.8 | -7588.9 | -2374.0 | -66028.8 | -174921.1 | -223184.9 | -5856646.5 | -23865150.8 | |
| P / FCF | · | -0.4 | -7.4 | -17.2 | -939.8 | · | · | -66014.1 | -174772.6 | -221791.8 | -5802618.5 | -23448736.8 | |
| EV / EBITDA | · | · | · | · | -331.5 | · | · | · | · | -168885.5 | -5787900.1 | -16023415.6 | |
| EV / FCF | · | · | · | · | -939.1 | · | · | · | · | -221790.8 | -5802618.3 | -23448735.3 | |
| EV / Revenue | · | · | · | · | 1026093.9 | · | · | · | · | 214530552.3 | 10643762204.9 | 14834697377.5 | |
| Earnings Yield | -12.8% | -617.6% | -305.2% | -21.2% | -17.4% | -0.09% | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $250.0K | $0 | $0 | |
| R&D Expense | $6M | $6M | · | · | · | · | $0 | $16M | · | · | $362.0K | · | · | · | · | · | |
| SG&A Expense | $5M | $4M | $4M | $2M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Operating Expenses | $12M | $11M | $10M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | |
| Operating Income | $-12M | $-11M | $-10M | $-3M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-3M | $-4M | $-4M | $-3M | $-4M | $-4M | |
| Interest Expense | · | · | · | $5.0K | $2.0K | $1.0K | · | $6.0K | $2.0K | $1.0K | $4.0K | $8.0K | $3.0K | $0 | $3.0K | $4.0K | |
| Other Non-op | $1M | $1M | $1M | $59.0K | $61.0K | $81.0K | $41.0K | $112.0K | $133.0K | $147.0K | $187.0K | $190.0K | $219.0K | $189.0K | $131.0K | $426.0K | |
| Net Income | $-11M | $-10M | $-9M | $-3M | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-3M | $-4M | $-3M | $-2M | $-4M | $-4M | |
| EPS (Basic) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| Shares (Basic) | 211,381,969 | 209,663,966 | · | 7,473,898 | 4,797,196 | 4,795,646 | · | 1,500,409 | 1,228,453 | 768,137 | · | 489,624 | 427,862 | 287,702 | · | 974,197 | |
| Shares (Diluted) | 211,381,969 | 209,663,966 | · | 7,473,898 | 4,797,196 | 4,795,646 | · | 1,500,409 | 1,228,453 | 768,137 | · | 489,624 | 427,862 | 287,702 | · | 974,197 | |
| EBITDA | $-12M | $-11M | · | $-3M | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-4M | $-4M | $-3M | · | $-4M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $133M | $133M | $5M | $5M | $7M | $10M | $8M | $11M | $11M | $12M | $15M | $16M | $13M | $12M | $14M | |
| Receivables | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | $250.0K | · | · | |
| Prepaid Expense | $2M | $615.0K | $836.0K | $2M | $1M | $657.0K | $673.0K | $830.0K | $959.0K | $737.0K | $896.0K | $954.0K | $1M | $762.0K | $2M | $1M | |
| Current Assets | $127M | $133M | $134M | $7M | $6M | $8M | $10M | $9M | $12M | $12M | $13M | $16M | $17M | $14M | $15M | $15M | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $2.0K | $3.0K | $3.0K | $4.0K | $5.0K | $10.0K | $10.0K | $11.0K | $9.0K | $10.0K | $12.0K | |
| Other Non-current Assets | $0 | $17.0K | $68.0K | $119.0K | $171.0K | $222.0K | $273.0K | $324.0K | $387.0K | $438.0K | $490.0K | $541.0K | $592.0K | $643.0K | $694.0K | $746.0K | |
| Total Assets | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Accounts Payable | $2M | $3M | $767.0K | $1M | $1M | $745.0K | $1M | $366.0K | $514.0K | $459.0K | $698.0K | $950.0K | $922.0K | $706.0K | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $831.0K | $794.0K | $598.0K | $309.0K | $574.0K | $1M | |
| Current Liabilities | $5M | $6M | $5M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $1M | $3M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $24.0K | $58.0K | $90.0K | $122.0K | $153.0K | $182.0K | $211.0K | $239.0K | |
| Other Non-current Liabilities | · | · | · | $283.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $4M | |
| Common Stock | $2M | $2M | $2M | $91.0K | $48.0K | $43.0K | $27.0K | $11.0K | $9.0K | $8.0K | $6.0K | $92.0K | $69.0K | $46.0K | $30.0K | $771.0K | |
| Paid-in Capital | $293M | $288M | $281M | $147M | $144M | $143M | $143M | $139M | $139M | $135M | $133M | $133M | $131M | $125M | $122M | $117M | |
| Retained Earnings | · | · | · | · | $141M | $138M | · | $133M | $-129M | $-125M | · | $118M | $115M | $112M | · | $105M | |
| Stockholders' Equity | $122M | $127M | $129M | $3M | $3M | $5M | $7M | $7M | $10M | $10M | $11M | $14M | $16M | $14M | $12M | $12M | |
| Liabilities + Equity | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Shares Outstanding | 173,595,201 | 167,421,702 | 159,444,017 | 9,119,152 | 4,800,247 | 4,396,646 | 2,768,646 | 1,198,516 | 966,345 | 851,302 | 618,056 | 9,210,751 | 6,849,362 | 4,563,977 | 2,944,306 | 77,080,169 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $2.0K | $1.0K | · | $0 | |
| Stock-based Comp | $5M | $4M | $4M | $90.0K | $69.0K | $69.0K | $77.0K | $95.0K | $362.0K | $118.0K | $185.0K | $202.0K | $144.0K | $93.0K | $86.0K | $252.0K | |
| Operating Cash Flow | $-8M | $-4M | $-3M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $10.0K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $-10.0K | $0 | |
| Stock Issued | $0 | $3M | $128M | $0 | $0 | $0 | $4M | $0 | $4M | $0 | $0 | $2M | $5M | $2M | $0 | $13M | |
| Net Stock Activity | · | $3M | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $147.0K | $3M | $131M | $3M | $4.0K | $-258.0K | $4M | $-180.0K | $4M | $2M | $-134.0K | $2M | $5M | $4M | $2M | $12M | |
| Net Change in Cash | $-7M | $-757.0K | $128M | $-190.0K | $-2M | $-3M | $2M | $-3M | $77.0K | $-1M | $-3M | $-1M | $3M | $914.0K | $-2M | $9M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| Net Margin | -2114.8% | · | · | · | · | · | · | · | · | · | · | · | · | -936.0% | · | · | |
| EBITDA Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| ROA | -15.8% | -13.6% | · | -35.2% | -28.5% | -21.4% | · | -26.4% | -26.2% | -25.3% | · | -21.6% | -26.0% | -19.8% | · | -24.5% | |
| ROE | -17.0% | -14.5% | · | -58.4% | -44.3% | -29.0% | · | -33.7% | -31.7% | -29.6% | · | -27.1% | -33.9% | -25.2% | · | -48.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.3 | 23.7 | · | 2.0 | 1.6 | 2.8 | · | 3.3 | 4.3 | 4.9 | · | 6.1 | 7.5 | 10.9 | · | 4.3 | |
| Quick Ratio | 24.0 | 23.6 | · | 1.5 | 1.4 | 2.6 | · | 3.0 | 4.0 | 4.6 | · | 5.8 | 7.0 | 10.3 | · | 4.0 | |
| Interest Coverage | · | · | · | -584.4 | -1421.5 | -2310.0 | · | -598.8 | -2105.5 | -3673.0 | · | -472.2 | -1203.0 | · | · | -1103.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | 1.8 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.70 | $0.76 | · | $0.35 | $0.55 | $1.21 | · | $5.51 | $10.30 | $11.82 | · | $1.53 | $2.31 | $3.01 | · | $0.16 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.06 | · | · | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.49 | · | · | · | $-4.14 | · | · | · | $-0.82 | · | · | |
| Cash / Share | $0.72 | $0.79 | · | $0.57 | $1.13 | $1.64 | · | $6.71 | $11.75 | $13.25 | · | $1.66 | $2.39 | $2.91 | · | $0.18 | |
| EPS (TTM) | $0.65 | $0.12 | · | $-1.39 | $-3.33 | $-6.07 | · | $-13.80 | $-18.86 | $-23.47 | · | $-17.14 | $-13.86 | $-11.70 | · | $-188.44 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $250.0K | $250.0K | $250.0K | · | · | |
| Net Income TTM | $-32M | $-24M | · | $-11M | $-12M | $-13M | · | $-14M | $-14M | $-13M | · | $-13M | $-13M | $-12M | · | $-9M | |
| Market Cap | $363M | $293M | · | $8M | $3M | $3M | · | $4M | $4M | $5M | · | $80M | $175M | $241M | · | $5.78B | |
| P/E | 3.2 | 14.6 | · | -0.6 | -0.2 | -0.1 | · | -0.3 | -0.2 | -0.3 | · | -0.5 | -1.8 | -4.5 | · | -0.4 | |
| P/S | 725.6 | · | · | · | · | · | · | · | · | · | · | 320.5 | 698.6 | 963.9 | · | · | |
| P/B | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Tangible Book | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Cash Flow | · | -75.3 | · | · | · | -1.3 | · | · | · | -1.6 | · | · | · | -68.3 | · | · | |
| Earnings Yield | 31.1% | 6.9% | · | -161.6% | -489.7% | -892.7% | · | -388.7% | -419.1% | -391.2% | · | -197.0% | -54.4% | -22.2% | · | -251.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | $0 | $250.0K | $0 | · |
| Margen Operativo % | · | · | -5228.0% | · | · |
| Beneficio neto | $-17M | $-14M | $-12M | $-14M | $-27M |
| EPS Diluido | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | · | · | · | 0.0 |
| Ratio corriente | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 |
| Ratio Rápido | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-12M | $-11M | $-13M | $-15M |
Propietarios institucionales (13F) 125 declarantes · $363.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
125
Valor en tenencia
$363.1M
Nuevas posiciones
50
Posiciones cerradas
21
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 50 (+19 vs trimestre anterior) | 21 (+1 vs trimestre anterior) | 33 (+4 vs trimestre anterior) | 23 (-2 vs trimestre anterior) | +24.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | $27 303 106 | 13 063 687 | 7,52% | Acciones |
| B Group, Inc. | $23 855 856 | 11 414 285 | 6,57% | Acciones |
| AMERIPRISE FINANCIAL INC | $23 160 197 | 11 081 434 | 6,38% | Acciones |
| BlackRock, Inc. | $21 812 829 | 10 436 760 | 6,01% | Acciones |
| Octagon Capital Advisors LP | $21 477 503 | 10 276 317 | 5,92% | Acciones |
| JANUS HENDERSON GROUP PLC | $18 759 988 | 10 689 452 | 5,17% | Acciones |
| PERCEPTIVE ADVISORS LLC | $17 608 386 | 8 425 065 | 4,85% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $14 889 402 | 7 124 116 | 4,10% | Acciones |
| FRANKLIN RESOURCES INC | $12 091 045 | 5 785 189 | 3,33% | Acciones |
| Point72 Asset Management, L.P. | $10 979 612 | 5 253 403 | 3,02% | Acciones |
| Boxer Capital Management, LLC | $10 031 739 | 4 799 875 | 2,76% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $9 405 000 | 4 500 000 | 2,59% | Acciones |
| Eversept Partners, LP | $8 742 021 | 4 182 785 | 2,41% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $7 861 359 | 3 760 485 | 2,17% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $7 741 226 | 3 703 936 | 2,13% | Acciones |
| GOLDMAN SACHS GROUP INC | $7 478 062 | 3 578 020 | 2,06% | Acciones |
| FEDERATED HERMES, INC. | $6 555 509 | 3 136 607 | 1,81% | Acciones |
| Squadron Capital Management LLC | $6 270 000 | 3 000 000 | 1,73% | Acciones |
| Propel Bio Management, LLC | $5 397 191 | 2 582 388 | 1,49% | Acciones |
| Vestal Point Capital, LP | $5 225 000 | 2 500 000 | 1,44% | Acciones |
| STATE STREET CORP | $5 174 104 | 2 475 648 | 1,43% | Acciones |
| MORGAN STANLEY | $5 170 803 | 2 474 069 | 1,42% | Acciones |
| VANGUARD GROUP INC | $4 971 711 | 2 115 622 | 1,37% | Acciones |
| ORBIMED ADVISORS LLC | $4 875 970 | 2 333 000 | 1,34% | Acciones |
| GREAT POINT PARTNERS LLC | $4 775 272 | 2 284 819 | 1,32% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $4 717 352 | 2 257 106 | 1,30% | Acciones |
| HighVista Strategies LLC | $4 244 638 | 2 030 927 | 1,17% | Acciones |
| Siren, L.L.C. | $4 180 000 | 2 000 000 | 1,15% | Acciones |
| Artia Global Partners LP | $4 164 047 | 1 992 367 | 1,15% | Acciones |
| Aberdeen Group plc | $3 992 328 | 1 910 205 | 1,10% | Acciones |
| Balyasny Asset Management L.P. | $3 920 200 | 1 875 694 | 1,08% | Acciones |
| PLATINUM INVESTMENT MANAGEMENT LTD | $3 617 510 | 1 730 866 | 1,00% | Acciones |
| ADAR1 Capital Management, LLC | $3 608 724 | 1 726 662 | 0,99% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 600 688 | 1 722 817 | 0,99% | Acciones |
| Ally Bridge Group (NY) LLC | $2 568 610 | 1 229 000 | 0,71% | Acciones |
| NORTHERN TRUST CORP | $2 503 026 | 1 197 620 | 0,69% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 350 832 | 1 124 800 | 0,65% | Acciones |
| CITADEL ADVISORS LLC | $2 125 216 | 1 016 850 | 0,59% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 077 659 | 994 095 | 0,57% | Acciones |
| Nuveen, LLC | $2 026 165 | 969 457 | 0,56% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 952 384 | 934 155 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 851 556 | 885 912 | 0,51% | Acciones |
| Ikarian Capital, LLC | $1 567 500 | 750 000 | 0,43% | Acciones |
| UBS Group AG | $1 540 972 | 737 307 | 0,42% | Acciones |
| BIT Capital GmbH | $1 199 660 | 574 000 | 0,33% | Acciones |
| Simplify Asset Management Inc. | $941 635 | 450 543 | 0,26% | Acciones |
| Creek Drive Management Group LLC | $919 600 | 440 000 | 0,25% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $913 616 | 437 137 | 0,25% | Acciones |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $912 758 | 436 726 | 0,25% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $909 114 | 434 983 | 0,25% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Yuma Regional Medical Center | 30 de agosto de 2021 | · | Presentación inicial | M&A / venta | SEC |
| Tianjin Pharmaceuticals Group Holdings Co., Ltd, Tianjin Pharmaceuticals Group International Holdings Co., Ltd | 27 de febrero de 2017 | · | Presentación inicial | Inversión pasiva | SEC |
| Karl Johe ×2 presentaciones | 4 de febrero de 2015 | · | Presentación inicial | · | SEC |
| I.Richard Garr | 4 de febrero de 2015 | · | Presentación inicial | · | SEC |
| I. Richard Garr | 6 de marzo de 2014 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 10 directivos · 22 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| John David Finley | CEO, CFO | 19 de agosto de 2026 G | 88 451 | 0 | 2 | $-310 690 |
| Thomas Hallam | Chief Executive Officer | 16 de agosto de 2022 P | 57 592 | 0 | 0 | $0 |
| Richard J Daly | Chief Executive Officer | 7 de noviembre de 2017 A | 23 312 | 0 | 0 | $0 |
| Richard Garr | CEO | 27 de enero de 2016 M | 1 449 804 | 0 | 0 | $0 |
| Jones Jonathan Brian Lloyd | Chief Financial Officer | 24 de marzo de 2017 P | 7 859 | 0 | 0 | $0 |
| John Conron | Chief Financial Officer | 28 de enero de 2011 A | 115 492 | 0 | 0 | $0 |
| Robert Curtis Mcrae | Chief Operating Officer | 3 de abril de 2023 M | 625 | 0 | 0 | $0 |
| Mitchell Lawrence Jones | Chief Medical Officer | 6 de julio de 2026 M | 94 009 | 0 | 2 | $-109 835 |
| Michael John Dawson | Chief Medical Officer | 29 de marzo de 2022 P | 15 000 | 0 | 0 | $0 |
| Karl Johe | Chief Scientific Officer | 19 de noviembre de 2015 M | 930 373 | 0 | 0 | $0 |
| Robert Baltera Jr. | Consejero | 9 de julio de 2026 P | 461 904 | 6 | 0 | $250 100 |
| Jordan Michael Zwick | Consejero | 10 de junio de 2026 A | 336 904 | 0 | 0 | $0 |
| Emil Chuang | Consejero | 10 de junio de 2026 M | 612 500 | 0 | 0 | $0 |
| Binxian Wei | Consejero | 10 de junio de 2026 M | 613 355 | 0 | 0 | $0 |
| Donald Allen Williams | Consejero | 10 de junio de 2026 M | 1 570 294 | 2 | 0 | $17 750 |
| Margery B. Fischbein | Consejero | 11 de julio de 2024 A | · | 0 | 0 | $0 |
| James R Neal | Consejero | 9 de febrero de 2024 M | 10 920 | 0 | 0 | $0 |
| Stephanie Diaz | Consejero | 8 de febrero de 2024 M | 12 800 | 0 | 0 | $0 |
| Robert J. Trenschel | Consejero | 8 de febrero de 2024 M | 10 920 | 0 | 0 | $0 |
| Cristina Csimma | Consejero | 8 de febrero de 2024 M | 12 862 | 0 | 0 | $0 |
| Mary Ann Gray | Consejero | 21 de noviembre de 2023 A | · | 0 | 0 | $0 |
| David J Mazzo | Consejero | 1 de abril de 2021 A | · | 0 | 0 | $0 |
| William Clyde Oldaker | Consejero | 1 de julio de 2019 A | 33 763 | 0 | 0 | $0 |
| Scott Varde Ogilvie | Consejero | 1 de julio de 2019 A | 86 020 | 0 | 0 | $0 |
| Sandford D Smith | Consejero | 1 de julio de 2019 A | 219 916 | 0 | 0 | $0 |
| Stanley Westreich | Consejero | 2 de julio de 2018 A | 143 281 | 0 | 0 | $0 |
| Catherine A. Sohn | Consejero | 1 de julio de 2015 A | 106 952 | 0 | 0 | $0 |
| REGAL ONE CORP | Propietario del 10% | 13 de marzo de 2007 J | 1 293 814 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 11 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,07% | 499 629 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 105 506 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 847 978 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 3 786 930 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 70 212 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 246 405 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 383 511 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 722 817 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 28 274 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 337 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 1 110 816 SH | 11 de septiembre de 2026 | Diario |
PALI Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 16 analistas
COMPRA
Objetivo mediano
$8.00
+455,6%
6 37,5%
Compra fuerte
9 56,2%
Compra
1 6,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
9 analistas · 2026-09-28Objetivo medio $10.22 +609,9%
← Por Debajo de Todos los Objetivos
Precio Actual $1.44
Mín$5.00
Media$10.22
Máx$25.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026